NEW YORK, July 7, 2020 /PRNewswire/ --
Global Biomarkers Market to Reach US$104.9 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Biomarkers estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$104.9 Billion by 2027, growing at a CAGR of 12.9% over the analysis period 2020-2027.Safety, one of the segments analyzed in the report, is projected to grow at a 12.5% CAGR to reach US$44.4 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Efficacy segment is readjusted to a revised 11.4% CAGR for the next 7-year period. This segment currently accounts for a 33.4% share of the global Biomarkers market.
Read the full report: https://www.reportlinker.com/p05818140/?utm_source=PRN
The U.S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 16.9% CAGR for the Period of 2020-2027
The Biomarkers market in the U.S. is estimated at US$12.1 Billion in the year 2020. The country currently accounts for a 26.98% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$23.4 Billion in the year 2027 trailing a CAGR of 17% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.1% and 11.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR while Rest of European market (as defined in the study) will reach US$23.4 Billion by the year 2027.
Validation Segment Corners a 23.2% Share in 2020
In the global Validation segment, USA, Canada, Japan, China and Europe will drive the 14.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$7.9 Billion in the year 2020 will reach a projected size of US$20.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$15.6 Billion by the year 2027, while Latin America will expand at a 17.1% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 546-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
-Competitors identified in this market include, among others,
- Abbott Molecular, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Epigenomics AG
- F. Hoffmann-La Roche AG
- Johnson & Johnson
- QIAGEN NV
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05818140/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Biomarkers Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Biomarkers Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2020-2027
Table 2: Biomarkers Global Retrospective Market Scenario in US$
Million by Region/Country: 2012-2019
Table 3: Biomarkers Market Share Shift across Key Geographies
Worldwide: 2012 VS 2020 VS 2027
Table 4: Safety (Type) World Market by Region/Country in US$
Million: 2020 to 2027
Table 5: Safety (Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Safety (Type) Market Share Breakdown of Worldwide
Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Efficacy (Type) Potential Growth Markets Worldwide in
US$ Million: 2020 to 2027
Table 8: Efficacy (Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: Efficacy (Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Validation (Type) Geographic Market Spread Worldwide
in US$ Million: 2020 to 2027
Table 11: Validation (Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019
Table 12: Validation (Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 13: Diagnostic (Application) Demand Potential Worldwide
in US$ Million by Region/Country: 2020-2027
Table 14: Diagnostic (Application) Historic Sales Analysis in
US$ Million by Region/Country: 2012-2019
Table 15: Diagnostic (Application) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027
Table 16: Drug Development (Application) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2020-2027
Table 17: Drug Development (Application) Global Historic
Analysis in US$ Million by Region/Country: 2012-2019
Table 18: Drug Development (Application) Distribution of Global
Sales by Region/Country: 2012 VS 2020 VS 2027
Table 19: Personalized Medicine (Application) Sales Estimates
and Forecasts in US$ Million by Region/Country for the Years
2020 through 2027
Table 20: Personalized Medicine (Application) Analysis of
Historic Sales in US$ Million by Region/Country for the Years
2012 to 2019
Table 21: Personalized Medicine (Application) Global Market
Share Distribution by Region/Country for 2012, 2020, and 2027
Table 22: Other Applications (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027
Table 23: Other Applications (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019
Table 24: Other Applications (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027
Table 25: Cancer (Disease) World Market by Region/Country in
US$ Million: 2020 to 2027
Table 26: Cancer (Disease) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 27: Cancer (Disease) Market Share Breakdown of Worldwide
Sales by Region/Country: 2012 VS 2020 VS 2027
Table 28: Cardiovascular Diseases (Disease) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027
Table 29: Cardiovascular Diseases (Disease) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019
Table 30: Cardiovascular Diseases (Disease) Market Sales
Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 31: Neurological Diseases (Disease) Geographic Market
Spread Worldwide in US$ Million: 2020 to 2027
Table 32: Neurological Diseases (Disease) Region Wise Breakdown
of Global Historic Demand in US$ Million: 2012 to 2019
Table 33: Neurological Diseases (Disease) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027
Table 34: Immunological Diseases (Disease) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027
Table 35: Immunological Diseases (Disease) Market Historic
Review by Region/Country in US$ Million: 2012 to 2019
Table 36: Immunological Diseases (Disease) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027
Table 37: Other Diseases (Disease) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 38: Other Diseases (Disease) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 39: Other Diseases (Disease) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Biomarkers Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 40: United States Biomarkers Market Estimates and
Projections in US$ Million by Type: 2020 to 2027
Table 41: Biomarkers Market in the United States by Type:
A Historic Review in US$ Million for 2012-2019
Table 42: United States Biomarkers Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 43: United States Biomarkers Latent Demand Forecasts in
US$ Million by Application: 2020 to 2027
Table 44: Biomarkers Historic Demand Patterns in the United
States by Application in US$ Million for 2012-2019
Table 45: Biomarkers Market Share Breakdown in the United
States by Application: 2012 VS 2020 VS 2027
Table 46: United States Biomarkers Market Estimates and
Projections in US$ Million by Disease: 2020 to 2027
Table 47: Biomarkers Market in the United States by Disease:
A Historic Review in US$ Million for 2012-2019
Table 48: United States Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
CANADA
Table 49: Canadian Biomarkers Market Estimates and Forecasts in
US$ Million by Type: 2020 to 2027
Table 50: Canadian Biomarkers Historic Market Review by Type in
US$ Million: 2012-2019
Table 51: Biomarkers Market in Canada: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 52: Canadian Biomarkers Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 53: Biomarkers Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 54: Canadian Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 55: Canadian Biomarkers Market Estimates and Forecasts in
US$ Million by Disease: 2020 to 2027
Table 56: Canadian Biomarkers Historic Market Review by Disease
in US$ Million: 2012-2019
Table 57: Biomarkers Market in Canada: Percentage Share
Breakdown of Sales by Disease for 2012, 2020, and 2027
JAPAN
Table 58: Japanese Market for Biomarkers: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027
Table 59: Biomarkers Market in Japan: Historic Sales Analysis
in US$ Million by Type for the Period 2012-2019
Table 60: Japanese Biomarkers Market Share Analysis by Type:
2012 VS 2020 VS 2027
Table 61: Japanese Demand Estimates and Forecasts for
Biomarkers in US$ Million by Application: 2020 to 2027
Table 62: Japanese Biomarkers Market in US$ Million by
Application: 2012-2019
Table 63: Biomarkers Market Share Shift in Japan by
Application: 2012 VS 2020 VS 2027
Table 64: Japanese Market for Biomarkers: Annual Sales
Estimates and Projections in US$ Million by Disease for the
Period 2020-2027
Table 65: Biomarkers Market in Japan: Historic Sales Analysis
in US$ Million by Disease for the Period 2012-2019
Table 66: Japanese Biomarkers Market Share Analysis by Disease:
2012 VS 2020 VS 2027
CHINA
Table 67: Chinese Biomarkers Market Growth Prospects in US$
Million by Type for the Period 2020-2027
Table 68: Biomarkers Historic Market Analysis in China in US$
Million by Type: 2012-2019
Table 69: Chinese Biomarkers Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 70: Chinese Demand for Biomarkers in US$ Million by
Application: 2020 to 2027
Table 71: Biomarkers Market Review in China in US$ Million by
Application: 2012-2019
Table 72: Chinese Biomarkers Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
Table 73: Chinese Biomarkers Market Growth Prospects in US$
Million by Disease for the Period 2020-2027
Table 74: Biomarkers Historic Market Analysis in China in US$
Million by Disease: 2012-2019
Table 75: Chinese Biomarkers Market by Disease: Percentage
Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Biomarkers Market: Competitor Market Share Scenario:
(in %) for 2019 & 2025
Market Analytics
Table 76: European Biomarkers Market Demand Scenario in US$
Million by Region/Country: 2020-2027
Table 77: Biomarkers Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2012-2019
Table 78: European Biomarkers Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 79: European Biomarkers Market Estimates and Forecasts in
US$ Million by Type: 2020-2027
Table 80: Biomarkers Market in Europe in US$ Million by Type:
A Historic Review for the Period 2012-2019
Table 81: European Biomarkers Market Share Breakdown by Type:
2012 VS 2020 VS 2027
Table 82: European Biomarkers Addressable Market Opportunity in
US$ Million by Application: 2020-2027
Table 83: Biomarkers Market in Europe: Summarization of
Historic Demand in US$ Million by Application for the Period
2012-2019
Table 84: European Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 85: European Biomarkers Market Estimates and Forecasts in
US$ Million by Disease: 2020-2027
Table 86: Biomarkers Market in Europe in US$ Million by
Disease: A Historic Review for the Period 2012-2019
Table 87: European Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
FRANCE
Table 88: Biomarkers Market in France by Type: Estimates and
Projections in US$ Million for the Period 2020-2027
Table 89: French Biomarkers Historic Market Scenario in US$
Million by Type: 2012-2019
Table 90: French Biomarkers Market Share Analysis by Type: 2012
VS 2020 VS 2027
Table 91: Biomarkers Quantitative Demand Analysis in France in
US$ Million by Application: 2020-2027
Table 92: French Biomarkers Historic Market Review in US$
Million by Application: 2012-2019
Table 93: French Biomarkers Market Share Analysis: A 17-Year
Perspective by Application for 2012, 2020, and 2027
Table 94: Biomarkers Market in France by Disease: Estimates and
Projections in US$ Million for the Period 2020-2027
Table 95: French Biomarkers Historic Market Scenario in US$
Million by Disease: 2012-2019
Table 96: French Biomarkers Market Share Analysis by Disease:
2012 VS 2020 VS 2027
GERMANY
Table 97: Biomarkers Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Type for the Period
2020-2027
Table 98: German Biomarkers Historic Market Analysis in US$
Million by Type: 2012-2019
Table 99: German Biomarkers Market Share Breakdown by Type:
2012 VS 2020 VS 2027
Table 100: Biomarkers Market in Germany: Annual Sales Estimates
and Forecasts in US$ Million by Application for the Period
2020-2027
Table 101: German Biomarkers Market in Retrospect in US$
Million by Application: 2012-2019
Table 102: Biomarkers Market Share Distribution in Germany by
Application: 2012 VS 2020 VS 2027
Table 103: Biomarkers Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Disease for the Period
2020-2027
Table 104: German Biomarkers Historic Market Analysis in US$
Million by Disease: 2012-2019
Table 105: German Biomarkers Market Share Breakdown by Disease:
2012 VS 2020 VS 2027
ITALY
Table 106: Italian Biomarkers Market Growth Prospects in US$
Million by Type for the Period 2020-2027
Table 107: Biomarkers Historic Market Analysis in Italy in US$
Million by Type: 2012-2019
Table 108: Italian Biomarkers Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 109: Italian Demand for Biomarkers in US$ Million by
Application: 2020 to 2027
Table 110: Biomarkers Market Review in Italy in US$ Million by
Application: 2012-2019
Table 111: Italian Biomarkers Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
Table 112: Italian Biomarkers Market Growth Prospects in US$
Million by Disease for the Period 2020-2027
Table 113: Biomarkers Historic Market Analysis in Italy in US$
Million by Disease: 2012-2019
Table 114: Italian Biomarkers Market by Disease: Percentage
Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
Table 115: United Kingdom Market for Biomarkers: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027
Table 116: Biomarkers Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Type for the Period 2012-2019
Table 117: United Kingdom Biomarkers Market Share Analysis by
Type: 2012 VS 2020 VS 2027
Table 118: United Kingdom Demand Estimates and Forecasts for
Biomarkers in US$ Million by Application: 2020 to 2027
Table 119: United Kingdom Biomarkers Market in US$ Million by
Application: 2012-2019
Table 120: Biomarkers Market Share Shift in the United Kingdom
by Application: 2012 VS 2020 VS 2027
Table 121: United Kingdom Market for Biomarkers: Annual Sales
Estimates and Projections in US$ Million by Disease for the
Period 2020-2027
Table 122: Biomarkers Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Disease for the Period
2012-2019
Table 123: United Kingdom Biomarkers Market Share Analysis by
Disease: 2012 VS 2020 VS 2027
SPAIN
Table 124: Spanish Biomarkers Market Estimates and Forecasts in
US$ Million by Type: 2020 to 2027
Table 125: Spanish Biomarkers Historic Market Review by Type in
US$ Million: 2012-2019
Table 126: Biomarkers Market in Spain: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 127: Spanish Biomarkers Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 128: Biomarkers Market in Spain: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 129: Spanish Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 130: Spanish Biomarkers Market Estimates and Forecasts in
US$ Million by Disease: 2020 to 2027
Table 131: Spanish Biomarkers Historic Market Review by Disease
in US$ Million: 2012-2019
Table 132: Biomarkers Market in Spain: Percentage Share
Breakdown of Sales by Disease for 2012, 2020, and 2027
RUSSIA
Table 133: Russian Biomarkers Market Estimates and Projections
in US$ Million by Type: 2020 to 2027
Table 134: Biomarkers Market in Russia by Type: A Historic
Review in US$ Million for 2012-2019
Table 135: Russian Biomarkers Market Share Breakdown by Type:
2012 VS 2020 VS 2027
Table 136: Russian Biomarkers Latent Demand Forecasts in US$
Million by Application: 2020 to 2027
Table 137: Biomarkers Historic Demand Patterns in Russia by
Application in US$ Million for 2012-2019
Table 138: Biomarkers Market Share Breakdown in Russia by
Application: 2012 VS 2020 VS 2027
Table 139: Russian Biomarkers Market Estimates and Projections
in US$ Million by Disease: 2020 to 2027
Table 140: Biomarkers Market in Russia by Disease: A Historic
Review in US$ Million for 2012-2019
Table 141: Russian Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 142: Rest of Europe Biomarkers Market Estimates and
Forecasts in US$ Million by Type: 2020-2027
Table 143: Biomarkers Market in Rest of Europe in US$ Million
by Type: A Historic Review for the Period 2012-2019
Table 144: Rest of Europe Biomarkers Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 145: Rest of Europe Biomarkers Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 146: Biomarkers Market in Rest of Europe: Summarization
of Historic Demand in US$ Million by Application for the Period
2012-2019
Table 147: Rest of Europe Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 148: Rest of Europe Biomarkers Market Estimates and
Forecasts in US$ Million by Disease: 2020-2027
Table 149: Biomarkers Market in Rest of Europe in US$ Million
by Disease: A Historic Review for the Period 2012-2019
Table 150: Rest of Europe Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 151: Asia-Pacific Biomarkers Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 152: Biomarkers Market in Asia-Pacific: Historic Market
Analysis in US$ Million by Region/Country for the Period
2012-2019
Table 153: Asia-Pacific Biomarkers Market Share Analysis by
Region/Country: 2012 VS 2020 VS 2027
Table 154: Biomarkers Market in Asia-Pacific by Type: Estimates
and Projections in US$ Million for the Period 2020-2027
Table 155: Asia-Pacific Biomarkers Historic Market Scenario in
US$ Million by Type: 2012-2019
Table 156: Asia-Pacific Biomarkers Market Share Analysis by
Type: 2012 VS 2020 VS 2027
Table 157: Biomarkers Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027
Table 158: Asia-Pacific Biomarkers Historic Market Review in
US$ Million by Application: 2012-2019
Table 159: Asia-Pacific Biomarkers Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027
Table 160: Biomarkers Market in Asia-Pacific by Disease:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 161: Asia-Pacific Biomarkers Historic Market Scenario in
US$ Million by Disease: 2012-2019
Table 162: Asia-Pacific Biomarkers Market Share Analysis by
Disease: 2012 VS 2020 VS 2027
AUSTRALIA
Table 163: Biomarkers Market in Australia: Recent Past, Current
and Future Analysis in US$ Million by Type for the Period
2020-2027
Table 164: Australian Biomarkers Historic Market Analysis in
US$ Million by Type: 2012-2019
Table 165: Australian Biomarkers Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 166: Biomarkers Market in Australia: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 167: Australian Biomarkers Market in Retrospect in US$
Million by Application: 2012-2019
Table 168: Biomarkers Market Share Distribution in Australia by
Application: 2012 VS 2020 VS 2027
Table 169: Biomarkers Market in Australia: Recent Past, Current
and Future Analysis in US$ Million by Disease for the Period
2020-2027
Table 170: Australian Biomarkers Historic Market Analysis in
US$ Million by Disease: 2012-2019
Table 171: Australian Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
INDIA
Table 172: Indian Biomarkers Market Estimates and Forecasts in
US$ Million by Type: 2020 to 2027
Table 173: Indian Biomarkers Historic Market Review by Type in
US$ Million: 2012-2019
Table 174: Biomarkers Market in India: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 175: Indian Biomarkers Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 176: Biomarkers Market in India: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 177: Indian Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 178: Indian Biomarkers Market Estimates and Forecasts in
US$ Million by Disease: 2020 to 2027
Table 179: Indian Biomarkers Historic Market Review by Disease
in US$ Million: 2012-2019
Table 180: Biomarkers Market in India: Percentage Share
Breakdown of Sales by Disease for 2012, 2020, and 2027
SOUTH KOREA
Table 181: Biomarkers Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027
Table 182: South Korean Biomarkers Historic Market Analysis in
US$ Million by Type: 2012-2019
Table 183: Biomarkers Market Share Distribution in South Korea
by Type: 2012 VS 2020 VS 2027
Table 184: Biomarkers Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Application for
the Period 2020-2027
Table 185: South Korean Biomarkers Historic Market Analysis in
US$ Million by Application: 2012-2019
Table 186: Biomarkers Market Share Distribution in South Korea
by Application: 2012 VS 2020 VS 2027
Table 187: Biomarkers Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Disease for the
Period 2020-2027
Table 188: South Korean Biomarkers Historic Market Analysis in
US$ Million by Disease: 2012-2019
Table 189: Biomarkers Market Share Distribution in South Korea
by Disease: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 190: Rest of Asia-Pacific Market for Biomarkers: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2020-2027
Table 191: Biomarkers Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Type for the Period 2012-2019
Table 192: Rest of Asia-Pacific Biomarkers Market Share
Analysis by Type: 2012 VS 2020 VS 2027
Table 193: Rest of Asia-Pacific Demand Estimates and Forecasts
for Biomarkers in US$ Million by Application: 2020 to 2027
Table 194: Rest of Asia-Pacific Biomarkers Market in US$
Million by Application: 2012-2019
Table 195: Biomarkers Market Share Shift in Rest of
Asia-Pacific by Application: 2012 VS 2020 VS 2027
Table 196: Rest of Asia-Pacific Market for Biomarkers: Annual
Sales Estimates and Projections in US$ Million by Disease for
the Period 2020-2027
Table 197: Biomarkers Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Disease for the Period
2012-2019
Table 198: Rest of Asia-Pacific Biomarkers Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 199: Latin American Biomarkers Market Trends by
Region/Country in US$ Million: 2020-2027
Table 200: Biomarkers Market in Latin America in US$ Million by
Region/Country: A Historic Perspective for the Period 2012-2019
Table 201: Latin American Biomarkers Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027
Table 202: Latin American Biomarkers Market Growth Prospects in
US$ Million by Type for the Period 2020-2027
Table 203: Biomarkers Historic Market Analysis in Latin America
in US$ Million by Type: 2012-2019
Table 204: Latin American Biomarkers Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 205: Latin American Demand for Biomarkers in US$ Million
by Application: 2020 to 2027
Table 206: Biomarkers Market Review in Latin America in US$
Million by Application: 2012-2019
Table 207: Latin American Biomarkers Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
Table 208: Latin American Biomarkers Market Growth Prospects in
US$ Million by Disease for the Period 2020-2027
Table 209: Biomarkers Historic Market Analysis in Latin America
in US$ Million by Disease: 2012-2019
Table 210: Latin American Biomarkers Market by Disease:
Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
Table 211: Argentinean Biomarkers Market Estimates and
Forecasts in US$ Million by Type: 2020-2027
Table 212: Biomarkers Market in Argentina in US$ Million by
Type: A Historic Review for the Period 2012-2019
Table 213: Argentinean Biomarkers Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 214: Argentinean Biomarkers Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 215: Biomarkers Market in Argentina: Summarization of
Historic Demand in US$ Million by Application for the Period
2012-2019
Table 216: Argentinean Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 217: Argentinean Biomarkers Market Estimates and
Forecasts in US$ Million by Disease: 2020-2027
Table 218: Biomarkers Market in Argentina in US$ Million by
Disease: A Historic Review for the Period 2012-2019
Table 219: Argentinean Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
BRAZIL
Table 220: Biomarkers Market in Brazil by Type: Estimates and
Projections in US$ Million for the Period 2020-2027
Table 221: Brazilian Biomarkers Historic Market Scenario in US$
Million by Type: 2012-2019
Table 222: Brazilian Biomarkers Market Share Analysis by Type:
2012 VS 2020 VS 2027
Table 223: Biomarkers Quantitative Demand Analysis in Brazil in
US$ Million by Application: 2020-2027
Table 224: Brazilian Biomarkers Historic Market Review in US$
Million by Application: 2012-2019
Table 225: Brazilian Biomarkers Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027
Table 226: Biomarkers Market in Brazil by Disease: Estimates
and Projections in US$ Million for the Period 2020-2027
Table 227: Brazilian Biomarkers Historic Market Scenario in US$
Million by Disease: 2012-2019
Table 228: Brazilian Biomarkers Market Share Analysis by
Disease: 2012 VS 2020 VS 2027
MEXICO
Table 229: Biomarkers Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Type for the Period
2020-2027
Table 230: Mexican Biomarkers Historic Market Analysis in US$
Million by Type: 2012-2019
Table 231: Mexican Biomarkers Market Share Breakdown by Type:
2012 VS 2020 VS 2027
Table 232: Biomarkers Market in Mexico: Annual Sales Estimates
and Forecasts in US$ Million by Application for the Period
2020-2027
Table 233: Mexican Biomarkers Market in Retrospect in US$
Million by Application: 2012-2019
Table 234: Biomarkers Market Share Distribution in Mexico by
Application: 2012 VS 2020 VS 2027
Table 235: Biomarkers Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Disease for the Period
2020-2027
Table 236: Mexican Biomarkers Historic Market Analysis in US$
Million by Disease: 2012-2019
Table 237: Mexican Biomarkers Market Share Breakdown by
Disease: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
Table 238: Rest of Latin America Biomarkers Market Estimates
and Projections in US$ Million by Type: 2020 to 2027
Table 239: Biomarkers Market in Rest of Latin America by Type:
A Historic Review in US$ Million for 2012-2019
Table 240: Rest of Latin America Biomarkers Market Share
Breakdown by Type: 2012 VS 2020 VS 2027
Table 241: Rest of Latin America Biomarkers Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027
Table 242: Biomarkers Historic Demand Patterns in Rest of Latin
America by Application in US$ Million for 2012-2019
Table 243: Biomarkers Market Share Breakdown in Rest of Latin
America by Application: 2012 VS 2020 VS 2027
Table 244: Rest of Latin America Biomarkers Market Estimates
and Projections in US$ Million by Disease: 2020 to 2027
Table 245: Biomarkers Market in Rest of Latin America by
Disease: A Historic Review in US$ Million for 2012-2019
Table 246: Rest of Latin America Biomarkers Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 247: The Middle East Biomarkers Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 248: Biomarkers Market in the Middle East by
Region/Country in US$ Million: 2012-2019
Table 249: The Middle East Biomarkers Market Share Breakdown by
Region/Country: 2012, 2020, and 2027
Table 250: The Middle East Biomarkers Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027
Table 251: The Middle East Biomarkers Historic Market by Type
in US$ Million: 2012-2019
Table 252: Biomarkers Market in the Middle East: Percentage
Share Breakdown of Sales by Type for 2012,2020, and 2027
Table 253: The Middle East Biomarkers Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027
Table 254: Biomarkers Market in the Middle East: Summarization
of Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 255: The Middle East Biomarkers Market Share Analysis by
Application: 2012 VS 2020 VS 2027
Table 256: The Middle East Biomarkers Market Estimates and
Forecasts in US$ Million by Disease: 2020 to 2027
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05818140/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article